The HDAC6-specific inhibitor AVS100 (SS208) blocks M2 polarization of tumor associated macrophages and potentiates immunotherapy in preclinical tumor models

AVS100 - Avstera

D. Kovalovsky 1; S. Noonepalle 2; M. Suresh 2; D. Kumar 1; M. Berrigan 3; A. Horvath 3; A. Kim 3; D. Quiceno-Torres 2; K. Musunuri 1; A. Villagra2

Mar 6, 2024